SYNCRIP and liver cancer: We are interested in the possible interaction between hnRNP Q (the synaptotagmin-binding cytoplasmic RNA interacting protein [SYNCRIP]) and LIN28 because abnormal levels of hnRNP Q have been implicated in several types of cancers, such as leukemia [39], liver cancer [40], and colorectal cancer [41].